PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 208 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $690,000 | +99.4% | 13,744 | +59.4% | 0.04% | +156.2% |
Q2 2022 | $346,000 | +7.5% | 8,625 | 0.0% | 0.02% | +23.1% |
Q1 2022 | $322,000 | -13.9% | 8,625 | -8.1% | 0.01% | 0.0% |
Q4 2021 | $374,000 | -23.5% | 9,388 | -28.5% | 0.01% | -13.3% |
Q3 2021 | $489,000 | -22.9% | 13,131 | -12.4% | 0.02% | 0.0% |
Q2 2021 | $634,000 | -10.7% | 14,989 | 0.0% | 0.02% | -11.8% |
Q1 2021 | $710,000 | -35.6% | 14,989 | -17.0% | 0.02% | -26.1% |
Q4 2020 | $1,102,000 | +21.5% | 18,063 | -6.9% | 0.02% | +15.0% |
Q3 2020 | $907,000 | -13.7% | 19,411 | -6.3% | 0.02% | -13.0% |
Q2 2020 | $1,051,000 | -12.7% | 20,712 | -23.3% | 0.02% | -20.7% |
Q1 2020 | $1,204,000 | -5.0% | 26,995 | +2.4% | 0.03% | +3.6% |
Q4 2019 | $1,267,000 | +111.5% | 26,375 | +48.9% | 0.03% | +100.0% |
Q3 2019 | $599,000 | -32.2% | 17,717 | -9.7% | 0.01% | -30.0% |
Q2 2019 | $883,000 | +99.8% | 19,617 | +67.1% | 0.02% | +100.0% |
Q1 2019 | $442,000 | +9.7% | 11,741 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $403,000 | – | 11,741 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |